Treatments Schizophrenia Invega Hafyera Print Save Invega Hafyera Generic name: paliperidone palmitate Dosage form: extended-release injectable suspension Drug class: Atypical antipsychotics Medically reviewed by Judith Stewart, BPharm. Last updated on Sep 2, 2021. Uses Warnings Before taking Interactions Dosage Side effects FAQ What is Invega Hafyera? Invega Hafyera is a prescription medicine given by injection by a healthcare provider 1 time every 6 months and used for the treatment of schizophrenia in adults who have been adequately treated with either: A 1 time each month paliperidone palmitate extended-release injectable suspension for at least 4 months. A 1 time every 3 months paliperidone palmitate extended-release injectable suspension for at least 3 months. It is not known if this medicine is safe and effective in children under 18 years of age. Important information Invega Hafyera may cause serious side effects, including: Increased risk of death in elderly people with dementia-related psychosis. Invega Hafyera increases the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). Invega Hafyera is not for the treatment of people with dementia-related psychosis. Who should not receive Invega Hafyera? You should not receive Invega Hafyera if you are allergic to paliperidone palmitate, risperidone, or any of the ingredients. See the end of this page for a complete list of ingredients. Invega Hafyera pregnancy and breastfeeding warnings (more detail) Before receiving Invega Hafyera Before you start treatment, tell your healthcare provider about all your medical conditions, including if you: have had Neuroleptic Malignant Syndrome (NMS) have or have had heart problems, including a heart attack, heart failure, abnormal heart rhythm, or long QT syndrome have or have had low levels of potassium or magnesium in your blood have or have had uncontrolled movements of your tongue, face, mouth, or jaw (tardive dyskinesia) have or have had kidney or liver problems have diabetes or have a family history of diabetes have Parkinson’s disease or a type of dementia called Lewy Body Dementia have had a low white blood cell count have had problems with dizziness or fainting or are being treated for high blood pressure have or have had seizures or epilepsy are pregnant or plan to become pregnant. It is not known if Invega Hafyera will harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment. If you become pregnant during treatment, talk to your healthcare provider about registering with the National Pregnancy Registry for Atypical Antipsychotics. You can register by calling 1-866-961-2388 or visit http://womensmentalhealth.org/clinical-and research-programs/pregnancyregistry/. Babies born to mothers who receive Invega Hafyera during their third trimester of pregnancy may develop agitation, low muscle tone (floppy baby syndrome) tremors, excessive sleepiness, breathing problems, and feeding problems. Tell your healthcare provider right away if your baby develops any of these symptoms. are breastfeeding or plan to breastfeed. Invega Hafyera can pass into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment. What other drugs will affect Invega Hafyera? Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Invega Hafyera and other medicines may affect each other causing possible serious side effects. Invega Hafyera may affect the way other medicines work, and other medicines may affect how Invega Hafyera works. Your healthcare provider can tell you if it is safe to receive Invega Hafyera with your other medicines. Do not start or stop any medicines during treatment without talking to your healthcare provider first. Know the medicines you take. Keep a list of them to show to your healthcare provider or pharmacist when you get a new medicine. Invega Hafyera drug interactions (more detail) How will I receive Invega Hafyera? Follow your treatment schedule exactly as your healthcare provider tells you to. Your healthcare provider will tell you how much Invega Hafyera you will receive and when you will receive it. Invega Hafyera is given as an injection by your healthcare provider into the muscle (intramuscularly) of your buttocks, 1 time every 6 months.
